Sensor systems, devices, and methods for continuous glucose monitoring

US11974844B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11974844-B2
Application numberUS-201916397156-A
CountryUS
Kind codeB2
Filing dateApr 29, 2019
Priority dateDec 28, 2015
Publication dateMay 7, 2024
Grant dateMay 7, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for first day calibration (FDC) of a glucose sensor for measuring the level of glucose in a body of a user, said glucose sensor including physical sensor electronics, a microcontroller, and a working electrode, the method comprising: (a) measuring, by said physical sensor electronics, the electrode current (Isig) for the working electrode; (b) determining, by said microcontroller, if the glucose sensor is in a FDC mode of operation following a successful calibration of the glucose sensor; (c) in response to the glucose sensor being in the FDC mode of operation following the successful calibration, determining, by said microcontroller, if the successful calibration was the first calibration of the glucose sensor following insertion of the glucose sensor into the body of the user; (d) in response to the successful calibration of the glucose sensor being the first calibration of the glucose sensor, calculating, by said microcontroller, a calibration ratio (CR) based on said Isig; (e) responsive to determining that the CR was calculated for the first calibration of the glucose sensor, comparing, by the microcontroller, said CR to a threshold range; (f) in response to the CR being outside of the threshold range, setting, by the microcontroller, a next calibration of the glucose sensor to be performed at a first time interval, wherein performance of the next calibration of the glucose sensor performed at the first time interval is based on an electrochemical impedance spectroscopy (EIS) procedure performed via the physical sensor electronics; and (g) in response to the CR being within the threshold range, setting by the microcontroller, the next calibration of the glucose sensor to be performed at a second time interval. 2. The method of claim 1 , wherein said threshold range is 4<CR<7. 3. The method of claim 1 , wherein the second time interval for the next calibration is 3 hours. 4. The method of claim 1 , wherein the first time interval for the next calibration is 6 hours. 5. The method of claim 1 , wherein the first time interval is greater than the second time interval.

Assignees

Inventors

Classifications

  • A61B5/1495Primary

    Calibrating or testing of in-vivo probes · CPC title

  • Measuring electrical impedance or conductance of a portion of the body · CPC title

  • Measuring body composition by impedance, e.g. tissue hydration or fat content · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • invasive, e.g. introduced into the body by a catheter · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11974844B2 cover?
Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.
Who is the assignee on this patent?
Medtronic Minimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/1495. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).